This review comprehensively presents recent research on SFN, elucidates its mechanism of action, and discusses potential therapeutic benefits for eye disorders such as age‐related macular degeneration (AMD), diabetic retinopathy (DR), cataracts, and other ophthalmic diseases. The gene discussed is SFN; the disease is age-related macular degeneration.